Below is a full list of the products marketed and commercialized in the US by OAPI that have been either developed, acquired, or in-licensed by Otsuka. Our product specialties include neuroscience, digital innovation, nephrology, oncology, and medical devices.
(aripiprazole) for extended release injectable suspension
(dextromethorphan HBr and quinidine sulfate) capsules
(aripiprazole tablets with sensor)